Bausch Health Companies Inc. buy exploration
Start price
20.09.16
/
50%
€24.53
Target price
03.11.16
€31.57
Performance (%)
-25.42%
End price
03.11.16
€18.30
Summary
This prediction ended on 03.11.16 with a price of €18.30. The price of Bausch Health Companies Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -25.42%. exploration has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bausch Health Companies Inc. | 6.085% | 6.085% | -10.278% | -23.460% |
| iShares Core DAX® | -1.586% | 5.028% | 6.332% | 64.061% |
| iShares Nasdaq 100 | -4.148% | -0.125% | 25.735% | 86.918% |
| iShares Nikkei 225® | -6.302% | 0.528% | 41.384% | 77.872% |
| iShares S&P 500 | -3.225% | 0.470% | 20.449% | 68.192% |
Comments by exploration for this prediction
In the thread Bausch Health Companies Inc. diskutieren
Valeant Pharma: auf lange Sicht ein Investment Wert
auf lange Sicht sind auch 45$ als Ziel erreichbar.
(Das Allzeit hoch lag bei 260$.)
(Stop Loss Kurs erreicht)
Stopped prediction by exploration for Bausch Health Companies Inc.
Bausch Health Companies Inc.
Start price
Target price
Perf. (%)
€22.59
07.06.18
07.06.18
€24.81
28.01.19
28.01.19
-3.49%
28.01.19
28.01.19
